The National Organization for the Reform of Marijuana Laws (NORML) has announced their endorsement of Missouri’s Amendment 2, which permits patients, at the discretion of a physician, to obtain cannabis and cannabis-infused products from licensed facilities.
The amendment is one of three competing ballot measures that seek to regulate medical cannabis use in Missouri. Of the three, NORML believes that Amendment 2 is written in a manner that best provides for the needs of patients and their physicians, and is the measure most likely to withstand scrutiny from lawmakers.
“This is a patient-centered proposal that puts power in the hands of state-licensed physicians and their patients, not politicians or bureaucrats. Passage of Amendment 2 will create a robust statewide system for production and sale of medical cannabis,” NORML Political Director Justin Strekal said. “Of the three proposals on the ballot this fall, we believe that Amendment 2 is the clear choice for voters.”
“The Amendment 2 campaign appreciates NORML’s endorsement, as well as many others we have received, including from the Missouri Epilepsy Foundation and Senator Claire McCaskill,” said Dan Viets, Board President of New Approach Missouri – the grassroots group that is sponsoring Amendment 2, and a member of NORML’s Board of Directors.
Amendment 2 is certified to appear on the November 2018 ballot. If passed by voters this fall, Missouri would become the 32nd state to legalize and regulate patients’ access to medical marijuana.